Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

EUSA Launches With $175M Financing, OPi Acquisition

March 2, 2007

By Jennifer Boggs

EndoCeutics Seeks $75M IPO For Hormone Therapy Trials

March 1, 2007

By Jennifer Boggs

Financings roundup: Rosetta Genomics’ IPO raising $26.3M for MicroRNA work

March 1, 2007

By Jennifer Boggs

EndoCeutics Seeks $75M IPO For Hormone Therapy Trials

March 1, 2007

By Jennifer Boggs

Rosetta Genomics' IPO Raising $26.3M For MicroRNA Work

Feb. 28, 2007

By Jennifer Boggs

Rosetta Genomics' IPO Raising $26.3M For MicroRNA Work

Feb. 28, 2007

By Jennifer Boggs

Adnexus Signs Deal With BMS For Adnectin Program

Feb. 27, 2007

By Jennifer Boggs

Adnexus Signs Deal With BMS For Adnectin Program

Feb. 27, 2007

By Jennifer Boggs

Chimerix's Antiviral Pipeline Attracts $23M VC Investment

Feb. 26, 2007

By Jennifer Boggs

Chimerix's Antiviral Pipeline Attracts $23M VC Investment

Feb. 26, 2007

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...